The hybrid closed loop system, approved by the Food and Drug Administration, automatically administers insulin to patients with type 1 diabetes. The system uses an algorithm to pump a specified amount of insulin to a patient every five minutes. It can be worn for up to seven days.
Poornima Jayaramaiah, MD, board-certified endocrinologist at Joslin Diabetes Center affiliate at HSHS Medical Group, said, “I’m confident this therapy will improve patient outcomes as demonstrated by the pivotal trial that studied the device, and enhance quality of life.”
More articles on supply chain:
Eli Lilly CFO to retire at year-end
Edwards Lifesciences’s heart valve earns FDA approval for new use
Nevada Governor vetoes diabetes drug price bill
